163 related articles for article (PubMed ID: 17666870)
1. [Molecular mechanism of neuroprotective drugs against oxidative stress-induced neuronal cell death].
Hara H
Yakugaku Zasshi; 2007 Aug; 127(8):1199-205. PubMed ID: 17666870
[TBL] [Abstract][Full Text] [Related]
2. Apomorphine protects against 6-hydroxydopamine-induced neuronal cell death through activation of the Nrf2-ARE pathway.
Hara H; Ohta M; Adachi T
J Neurosci Res; 2006 Sep; 84(4):860-6. PubMed ID: 16802348
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotection against 6-OHDA-induced oxidative stress and apoptosis in SH-SY5Y cells by 5,7-Dihydroxychromone: Activation of the Nrf2/ARE pathway.
Kim DW; Lee KT; Kwon J; Lee HJ; Lee D; Mar W
Life Sci; 2015 Jun; 130():25-30. PubMed ID: 25818191
[TBL] [Abstract][Full Text] [Related]
4. Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tert-butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult.
Kraft AD; Johnson DA; Johnson JA
J Neurosci; 2004 Feb; 24(5):1101-12. PubMed ID: 14762128
[TBL] [Abstract][Full Text] [Related]
5. Critical role of Nrf2 in oxidative stress-induced retinal ganglion cell death.
Himori N; Yamamoto K; Maruyama K; Ryu M; Taguchi K; Yamamoto M; Nakazawa T
J Neurochem; 2013 Dec; 127(5):669-80. PubMed ID: 23721546
[TBL] [Abstract][Full Text] [Related]
6. Nrf2/ARE regulated antioxidant gene expression in endothelial and smooth muscle cells in oxidative stress: implications for atherosclerosis and preeclampsia.
Mann GE; Niehueser-Saran J; Watson A; Gao L; Ishii T; de Winter P; Siow RC
Sheng Li Xue Bao; 2007 Apr; 59(2):117-27. PubMed ID: 17437032
[TBL] [Abstract][Full Text] [Related]
7. Activation of the Keap1/Nrf2 pathway for neuroprotection by electrophilic [correction of electrophillic] phase II inducers.
Satoh T; Okamoto SI; Cui J; Watanabe Y; Furuta K; Suzuki M; Tohyama K; Lipton SA
Proc Natl Acad Sci U S A; 2006 Jan; 103(3):768-73. PubMed ID: 16407140
[TBL] [Abstract][Full Text] [Related]
8. The Nrf2-ARE Signalling pathway: promising drug target to combat oxidative stress in neurodegenerative disorders.
van Muiswinkel FL; Kuiperij HB
Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):267-81. PubMed ID: 15975029
[TBL] [Abstract][Full Text] [Related]
9. 4-Hydroperoxy-2-decenoic acid ethyl ester protects against 6-hydroxydopamine-induced cell death via activation of Nrf2-ARE and eIF2α-ATF4 pathways.
Inoue Y; Hara H; Mitsugi Y; Yamaguchi E; Kamiya T; Itoh A; Adachi T
Neurochem Int; 2018 Jan; 112():288-296. PubMed ID: 28823537
[TBL] [Abstract][Full Text] [Related]
10. Tanshinone IIA protects dopaminergic neurons against 6-hydroxydopamine-induced neurotoxicity through miR-153/NF-E2-related factor 2/antioxidant response element signaling pathway.
Zhang XS; Ha S; Wang XL; Shi YL; Duan SS; Li ZA
Neuroscience; 2015 Sep; 303():489-502. PubMed ID: 26116522
[TBL] [Abstract][Full Text] [Related]
11. Bromocriptine activates NQO1 via Nrf2-PI3K/Akt signaling: novel cytoprotective mechanism against oxidative damage.
Lim JH; Kim KM; Kim SW; Hwang O; Choi HJ
Pharmacol Res; 2008 May; 57(5):325-31. PubMed ID: 18455424
[TBL] [Abstract][Full Text] [Related]
12. Naringenin protects against 6-OHDA-induced neurotoxicity via activation of the Nrf2/ARE signaling pathway.
Lou H; Jing X; Wei X; Shi H; Ren D; Zhang X
Neuropharmacology; 2014 Apr; 79():380-8. PubMed ID: 24333330
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of lipoic acid against oxidative stress is mediated by Keap1/Nrf2-dependent heme oxygenase-1 induction in the RGC-5 cellline.
Koriyama Y; Nakayama Y; Matsugo S; Kato S
Brain Res; 2013 Mar; 1499():145-57. PubMed ID: 23295186
[TBL] [Abstract][Full Text] [Related]
14. An Overview of the Nrf2/ARE Pathway and Its Role in Neurodegenerative Diseases.
Zgorzynska E; Dziedzic B; Walczewska A
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502501
[TBL] [Abstract][Full Text] [Related]
15. Apomorphine, a dopamine receptor agonist with remarkable antioxidant and cytoprotective properties.
Gassen M; Gross A; Youdim MB
Adv Neurol; 1999; 80():297-302. PubMed ID: 10410734
[No Abstract] [Full Text] [Related]
16. Dual neuroprotective pathways of a pro-electrophilic compound via HSF-1-activated heat-shock proteins and Nrf2-activated phase 2 antioxidant response enzymes.
Satoh T; Rezaie T; Seki M; Sunico CR; Tabuchi T; Kitagawa T; Yanagitai M; Senzaki M; Kosegawa C; Taira H; McKercher SR; Hoffman JK; Roth GP; Lipton SA
J Neurochem; 2011 Nov; 119(3):569-78. PubMed ID: 21883218
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective Effects of Tanshinone I Against 6-OHDA-Induced Oxidative Stress in Cellular and Mouse Model of Parkinson's Disease Through Upregulating Nrf2.
Jing X; Wei X; Ren M; Wang L; Zhang X; Lou H
Neurochem Res; 2016 Apr; 41(4):779-86. PubMed ID: 26537816
[TBL] [Abstract][Full Text] [Related]
18. The Nrf2-ARE pathway: a valuable therapeutic target for the treatment of neurodegenerative diseases.
Joshi G; Johnson JA
Recent Pat CNS Drug Discov; 2012 Dec; 7(3):218-29. PubMed ID: 22742419
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of bromocriptine against BH4-induced Cath.a cell death involving up-regulation of antioxidant enzymes.
Lim JH; Kim SS; Boo DH; No H; Kang BY; Kim EM; Hwang O; Choi HJ
Neurosci Lett; 2009 Feb; 451(3):185-9. PubMed ID: 19146917
[TBL] [Abstract][Full Text] [Related]
20. Nuclear factor erythroid 2-related factor 2 signaling in Parkinson disease: a promising multi therapeutic target against oxidative stress, neuroinflammation and cell death.
Kumar H; Koppula S; Kim IS; More SV; Kim BW; Choi DK
CNS Neurol Disord Drug Targets; 2012 Dec; 11(8):1015-29. PubMed ID: 23244425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
